[topsearch__bar__shortcode]

October 2024

Annovis Bio (ANVS) Stock Soars After FDA Approval

A recent regulatory approval from the U.S. Food and Drug Administration (FDA) has led to a substantial rise in the stock price of Annovis Bio, Inc. (NYSE: ANVS). As of the latest update, ANVS shares have increased by 6.72%, trading at $8.02. This upward trajectory is largely attributed to the announcement of a successful End-of-Phase […]

Annovis Bio (ANVS) Stock Soars After FDA Approval Read More »

Oklo Stock Gains Momentum After Important Regulatory Milestone

In a noteworthy development, shares of Oklo Inc. (NYSE: OKLO) experienced a substantial increase of 18.92%, rising to $11.94 following the recent approval from the U.S. Department of Energy (DOE) for its Conceptual Safety Design Report (CSDR). This pivotal endorsement marks a crucial step as Oklo aims to harness recovered nuclear materials to fuel its

Oklo Stock Gains Momentum After Important Regulatory Milestone Read More »

MeiraGTx (MGTX) Sees Stock Surge Following Promising Clinical Study Results

Following the release of encouraging findings from its clinical research, shares of MeiraGTx Holdings plc (NASDAQ: MGTX) have seen a significant boost, reaching $5.25, or 13.15%, in value. Top-line data from the company’s clinical bridging trial, MGT-GAD-025, which focused on AAV-GAD as a possible Parkinson’s disease therapy, was released. Promising Safety and Efficacy Results The

MeiraGTx (MGTX) Sees Stock Surge Following Promising Clinical Study Results Read More »

Rumble (RUM) Stock Soars Following New Cloud Client Acquisition

Shares of Rumble Inc. (NASDAQ: RUM) were trading at $6.27 as of the last check with a major increase of 14.71%. This growing trend comes after RUM announced that it had secured a significant new client in the cloud services industry, strengthening its position in the market. Partnership with Sticker Mule The innovative online custom

Rumble (RUM) Stock Soars Following New Cloud Client Acquisition Read More »

Immuneering (IMRX) Shares Surge After FDA Grants Orphan Drug Designation

After a big regulatory notification, Immuneering Corporation’s (NASDAQ: IMRX) stock price has increased significantly, rising 12.99% to $2.26. After the U.S. Food and medicine Administration (FDA) designated its primary experimental medication, IMM-1-104, as an orphan medicine to treat pancreatic cancer, this rise follows. This acknowledgment highlights how IMM-1-104 may be able to fill a significant

Immuneering (IMRX) Shares Surge After FDA Grants Orphan Drug Designation Read More »

Wolfspeed (WOLF) Stock Rises Amid Proposed CHIPS Act Funding Agreement

Following the announcement of a proposed fundraising endeavor, the stock value of Wolfspeed, Inc. (NYSE: WOLF) has increased 21.97% to $13.88. A strategic relationship with the U.S. Department of Commerce, which led to the signing of a non-binding preliminary memorandum of agreement (PMT) proposing up to $750 million in direct support under the CHIPS and Science

Wolfspeed (WOLF) Stock Rises Amid Proposed CHIPS Act Funding Agreement Read More »

Banzai (BNZI) Stock Rises In Pre-Market Following Strategic Collaboration

The stock value of Banzai International, Inc. (NASDAQ: BNZI) has experienced a noteworthy surge, increasing by 44.86% to $5.36 during today’s pre-market session. The company’s recent hiring of MZ Group, a well-known global investor relations expert, is responsible for this increase. The goal of the partnership is to increase Banzai’s visibility and presence in important

Banzai (BNZI) Stock Rises In Pre-Market Following Strategic Collaboration Read More »

Acquisition News Sparks Pre-Market Stock Rally For Longboard (LBPH)

As of the most recent check, the stock price of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) has risen 51.62% to $58.98, a significant increase during pre-market activity. The news of a purchase deal by the multinational pharmaceutical company H. Lundbeck A/S caused LBPH shares to soar. The agreement was a strategic effort by Lundbeck to raise

Acquisition News Sparks Pre-Market Stock Rally For Longboard (LBPH) Read More »

Inventiva (IVA) Sees Pre-Market Rise After Securing Key Funding

Inventiva S.A. (NASDAQ: IVA) is seeing its shares surge significantly following the announcement of substantial financing aimed at advancing its clinical research. As of the last check during the pre-market session, IVA stock rose to $3.18, marking a 68.25% increase. This surge reflects market confidence in the company’s recent developments and future prospects, particularly in

Inventiva (IVA) Sees Pre-Market Rise After Securing Key Funding Read More »

Eco Wave Power Sees Significant Stock Boost After Taiwan Power Deal

Eco Wave Power Global AB (NASDAQ: WAVE) experienced a significant boost in its stock price, continuing a rally from the previous day. By the close of trading last Friday, WAVE shares surged by 16.30%, reaching $6.60. This rise contributed to an overall weekly increase of 19.35%. The stock’s upward trajectory was fueled by a power

Eco Wave Power Sees Significant Stock Boost After Taiwan Power Deal Read More »